• Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • it
  • en

09 July 2013

WEEK END DI ALTI E BASSI PER CELADRIN MSR CORSE

Azcarate brillante in prova, sfortunato in gara

28 June 2013

Celadrin corre con… GIOIA!

GIOIA RUNNING - 23 giugno 2013 - Gioia del Colle

Corri con... Gioia", gara podistica regionale con un percorso di 10 chilometri,

28 June 2013

Celadrin con Formula Medicine in F1

Dalla gara di Silverstone , Celadrin è nuovo partner di Formula Medicine in Formula 1.

10 June 2013

I VINCITORI DELLA 151 MIGLIA-TROFEO CELADRIN

Gran finale per la 151 Miglia-Trofeo Celadrin, la regata d'altura organizzata dallo Yacht Club Punta Ala 

28 May 2013

È RECORD DI ISCRITTI ALLA 151 MIGLIA-TROFEO CELADRIN

Nel pomeriggio di giovedì 30 maggio, la 151 Miglia-Trofeo Celadrin è già pronta a festeggiare l'ultimo dei tanti record accumulati in neanche quattro anni di vita.

27 May 2013

Celadrin per Deejay Ten

26 MAGGIO - FIRENZE
Deejay TEN

21 May 2013

CELADRIN MSR CORSE FERMATA IN CASA

Amaro in bocca per la Celadrin MSR Corse costretta al ritiro per un guasto tecnico

21 May 2013

Prysmian Celadrin Trophy 2013

Terminato a Punta Ala il Prysmian Celadrin Trophy 2013, evento che racchiudeva il Trofeo Gavitello d'Argento e l'International Sailing Week

21 May 2013

UN ALTRO COLPO MESSO A SEGNO DALLA CELADRIN MSR CORSE

L’ex F1 Enrique Bernoldi ingaggiato per la prima gara a Barcellona 

< 1 … 27 28

PharmaNutra Spa

Registered office

Via Delle Lenze, 216/b - 56122 Pisa

Phone +39 050 7846500

Fax +39 050 7846524

Electronic billing code

SUBM70N

C.F. / P.Iva / Reg. Impr. 01679440501

Share capital € 1.123.097,70

I.V. | REA 146259

Contacts

Info
info@pharmanutra.it
Commerciale
commerciale@pharmanutra.it
Investor relations
investorrelation@pharmanutra.it
Distribution
internationaldept@pharmanutra.it

Product sites

sideral.it

cetilar.it

ultramag.it

apportal.it

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.
Read Newsletter Disclosure

Subscribe to the newsletter
Privacy policy Cookie policy General conditions PRIVACY INFORMATION FOR CUSTOMERS

© 2022 2020 PharmaNutra SpA - All rights reserved